Trademark: 90383773
Word
PANDA
Status
Registered
Status Code
700
Status Date
Tuesday, December 27, 2022
Serial Number
90383773
Registration Number
6937272
Registration Date
Tuesday, December 27, 2022
Mark Type
4000
Filing Date
Tuesday, December 15, 2020
Published for Opposition
Tuesday, March 29, 2022

Trademark Owner History
EpiVax, Inc. - Original Registrant

Classifications
44 Health screening services in the field of immunogenicity; Providing medical information to scientists in the form of reports in the field of immunogenicity
42 Scientific and technical services, namely, analysis and testing of protein therapeutic sequences in the field of immunogenicity

Trademark Events
Dec 27, 2022
Notice Of Registration Confirmation Emailed
Dec 27, 2022
Registered-Principal Register
Nov 24, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 23, 2022
Allowed Principal Register - Sou Accepted
Nov 18, 2022
Statement Of Use Processing Complete
Oct 31, 2022
Use Amendment Filed
Nov 18, 2022
Case Assigned To Intent To Use Paralegal
Oct 31, 2022
Teas Statement Of Use Received
Sep 21, 2022
Teas Change Of Correspondence Received
Sep 21, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 21, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 24, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 29, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 29, 2022
Published For Opposition
Mar 9, 2022
Notification Of Notice Of Publication E-Mailed
Nov 23, 2021
Withdrawn From Pub - Og Review Query
Nov 5, 2021
Approved For Pub - Principal Register
Oct 16, 2021
Teas/Email Correspondence Entered
Oct 15, 2021
Correspondence Received In Law Office
Oct 15, 2021
Teas Response To Office Action Received
Jun 8, 2021
Notification Of Non-Final Action E-Mailed
Jun 8, 2021
Non-Final Action E-Mailed
Jun 8, 2021
Non-Final Action Written
Jun 8, 2021
Assigned To Examiner
Feb 23, 2021
New Application Office Supplied Data Entered In Tram
Dec 18, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24